SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Tellurian Inc. (TELL) .
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+383.5%).
- Analyst consensus target $4.83 (+383.5% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 42/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — TELL
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio3.40
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.29
Book Value / Share$0.00
Revenue / Share$0.29
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$4.83 (+383.5%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$-7.53 |
$1.46M |
$-43M |
-2945.2% |
| 2015 |
$-3.06 |
$1.69M |
$-17.58M |
-1042.5% |
| 2016 |
$-1.01 |
$31K |
$-96.66M |
-311790.3% |
| 2017 |
$-1.23 |
$5.44M |
$-231.46M |
-4254% |
| 2018 |
$-0.59 |
$10.29M |
$-125.75M |
-1222.5% |
| 2019 |
$-0.69 |
$28.77M |
$-151.77M |
-527.4% |
| 2020 |
$-0.79 |
$37.43M |
$-210.7M |
-562.8% |
| 2021 |
$-0.28 |
$71.28M |
$-114.74M |
-161% |
| 2022 |
$-0.09 |
$391.93M |
$-49.81M |
-12.7% |
| 2023 |
$-0.29 |
$166.13M |
$-166.18M |
-100% |
